BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29556337)

  • 1. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 2. Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinoma.
    Liu SX; Wang C; Lin RB; Ding WY; Roy G; Wang HB; Yang T; Liu Q; Luo YL; Jin SL; Zeng MS; Zhao B; Zhong Q
    EBioMedicine; 2023 Dec; 98():104870. PubMed ID: 37967508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.
    Metwalli AR; Khanbolooki S; Jinesh G; Sundi D; Shah JB; Shrader M; Choi W; Lashinger LM; Chunduru S; McConkey DJ; McKinlay M; Kamat AM
    Cancer Biol Ther; 2010 Nov; 10(9):885-92. PubMed ID: 20814238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
    Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
    J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting RPA promotes autophagic flux and the antitumor response to radiation in nasopharyngeal carcinoma.
    Feng Y; Jiang Y; Liu J; Liu J; Shi M; Chen J; Zhang J; Tian Y; Yang X; Liu H
    J Transl Med; 2023 Oct; 21(1):738. PubMed ID: 37858134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63.
    Chow SE; Chang YL; Chuang SF; Wang JS
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):835-45. PubMed ID: 21207227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
    Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
    Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
    Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
    Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
    Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
    Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
    Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line.
    Su J; Xu XH; Huang Q; Lu MQ; Li DJ; Xue F; Yi F; Ren JH; Wu YP
    Arch Med Res; 2011 Jan; 42(1):15-21. PubMed ID: 21376257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CENPN suppresses autophagy and increases paclitaxel resistance in nasopharyngeal carcinoma cells by inhibiting the CREB-VAMP8 signaling axis.
    Wang BR; Han JB; Jiang Y; Xu S; Yang R; Kong YG; Tao ZZ; Hua QQ; Zou Y; Chen SM
    Autophagy; 2024 Feb; 20(2):329-348. PubMed ID: 37776538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.
    Cao JY; Liu L; Chen SP; Zhang X; Mi YJ; Liu ZG; Li MZ; Zhang H; Qian CN; Shao JY; Fu LW; Xia YF; Zeng MS
    Mol Cancer; 2010 Sep; 9():237. PubMed ID: 20828406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Skp2 overexpression to prognosis of patients with nasopharyngeal carcinoma from South China.
    Xu HM; Liang Y; Chen Q; Wu QN; Guo YM; Shen GP; Zhang RH; He ZW; Zeng YX; Xie FY; Kang TB
    Chin J Cancer; 2011 Mar; 30(3):204-12. PubMed ID: 21352698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel effects of statins in enhancing efficacy of chemotherapy in vitro in nasopharyngeal carcinoma.
    Wang W; Le W; Cho DY; Hwang PH; Upadhyay D
    Int Forum Allergy Rhinol; 2011; 1(4):284-9. PubMed ID: 22287433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regorafenib inhibits growth, survival and angiogenesis in nasopharyngeal carcinoma and is synergistic with Mcl-1 inhibitor.
    Li J; Hua Q
    J Pharm Pharmacol; 2023 Sep; 75(9):1177-1185. PubMed ID: 37133348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
    Cao L; Zhou Y; Zhai B; Liao J; Xu W; Zhang R; Li J; Zhang Y; Chen L; Qian H; Wu M; Yin Z
    BMC Gastroenterol; 2011 Jun; 11():71. PubMed ID: 21669008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic action of Hedyotis diffusa Willd and Andrographis paniculata in Nasopharyngeal Carcinoma: Downregulating AKT1 and upregulating VEGFA to curb tumorigenesis.
    Ye C; Zhang B; Tang Z; Zheng C; Wang Q; Tong X
    Int Immunopharmacol; 2024 May; 132():111866. PubMed ID: 38603854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.
    Lim YC; Oh SY; Cha YY; Kim SH; Jin X; Kim H
    Oral Oncol; 2011 Feb; 47(2):83-91. PubMed ID: 21167769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, Molecular Docking, and Tumor Resistance Reversal Activity Evaluation of Matrine Derivative with Thiophene Structure.
    Wei J; Liang Y; Wu L
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.